Searched for
SWISS DRUGMAKER
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- Global Markets: European shares edge higher with banks in the lead; the Middle East in focusEuropean markets saw a rise on Tuesday. Banking stocks led the gains, with Italian lenders drawing attention. Tech stocks stabilized after ...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
- Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
- Global Markets | European shares subdued as US-Iran talks stall; corporate earnings on tapEuropean shares were muted on Tuesday as investors braced for a week packed with central bank meetings and corporate earnings, while weighi...
- Novartis to buy experimental breast cancer drug in up to $3 billion dealSwiss drugmaker Novartis is set to acquire a promising breast cancer drug candidate from US biotech firm Synnovation Therapeutics. The deal...
- Roche ramps up AI computing capacity with Nvidia chip expansionRoche said the additional hardware would speed up work across its research and development operations, including modelling, data analysis...
- Novartis signs up to $5.2 billion heart drugs licensing deal with China's ArgoNovartis has entered into a licensing and options agreement with Argo Biopharmaceutical, valued at up to $5.2 billion. The deal encompasses...
- Moderna plans mix of COVID-19 vaccine doses with new Lonza dealIt has agreed a deal with Swiss-based drugmaker Lonza which said a new drug substance production line in Geleen, Netherlands, will have cap...
- Roche links with Moderna to include antibody test in COVID-19 vaccine trialRoche said the test can provide quantitative evidence of the presence and levels of antibodies that develop in response to the vaccine cand...
- Swiss drugmaker Roche says demand for Covid-19 tests exceeds production"The demand exceeds our production," Christoph Franz was quoted as saying in Saturday's paper. The decision on where tests were shipped to ...
- Roche says prostate cancer drug hit one trial goal, missed anotherSwiss drugmaker Roche said on Friday its experimental medicine ipatasertib hit one goal of a late-stage clinical trial against a small slic...
- IPAB dismisses Bayer's stay plea in Nexavar caseIPAB of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmake...
- Cipla’s patent win against Roche boosts hopes of generic drugmakersThe Delhi HC ruling favouring India’s second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fightin...
- Jupiter Biosciences in talks to buy Swiss pharma co for $10 mHyderabad-based Jupiter Biosciences is in talks to buy privately held Swiss pharma company SynphaBase AG for about $10 million as it looks ...
- Nestle starts 10 bln franc share buyback programmeNestle, the world's biggest food group, will start its 10 billion Swiss franc ($8.85 billion) share buyback programme on June 29 and expect...
- Swiss drugmaker Roche completes Genentech takeoverSwiss pharmaceutical giant Roche said it has completed its $46.8 billion takeover of California-based biotech firm Genentech.
- Swiss drugmaker Novartis to cut 2,500 jobsSwiss drugmaker Novartis said plans to cut 2,500 jobs in a restructuring programme aimed at generating yearly cost savings of 1.6 billion d...
Load More
